Skip to content
OpenCapital
Get started

Journey Medical Corporation DERM EV / sales

EV / sales at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
2×-0.3×
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
1×-0.2×
PTH
Pelthos Therapeutics Inc.PTHS
2.5×—
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
7.2×-1.8×
HRO
HarrowHROW
5.7×-0.6×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
3.8×-0.6×

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M—
Free cash flow-$6.0M—

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S3×+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%—
Net margin-14.8%—
FCF margin-43%—

Returns & leverage

See full
Return on equity-36.6%—
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Calculated from Journey Medical Corporation’s reported figures.

enterprise value/total revenue=2×

Based on the most recent quarter.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's EV / sales?
Journey Medical Corporation (DERM) reported EV / sales of 2× in Q1 2026.
How has Journey Medical Corporation's EV / sales changed year-over-year?
Journey Medical Corporation's EV / sales decreased by 21.7% year-over-year, from 2.5× to 2×.
What is the long-term trend for Journey Medical Corporation's EV / sales?
Over 4 years (2021 to 2025), Journey Medical Corporation's EV / sales has grown at a 48.5% compound annual growth rate (CAGR), from 0.7× to 3.4×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.